Vitexicarpin
Cat.No:IV0300 Solarbio
CAS:479-91-4
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
{{cart_num}}
My Cart>
Small Molecule Compounds >
Inhibitors & Antagonists & Agonists >
JAK/STAT >
VitexicarpinCAS:479-91-4
Storage:Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year
Purity:HPLC≥98%
Appearance:Light yellow to yellow Solid
Qty:
Size:
CAS | 479-91-4 |
Name | Vitexicarpin |
Molecular Formula | C19H18O8 |
Molecular Weight | 374.34 |
Solubility | Soluble in DMSO |
Purity | HPLC≥98% |
Appearance | Light yellow to yellow Solid |
Storage | Powder:2-8℃,2 years;Insolvent(Mother Liquid):-20℃,6 months;-80℃,1 year |
MDL | MFCD00210481 |
SMILES | O=C1C(OC)=C(C2=CC=C(OC)C(O)=C2)OC3=CC(OC)=C(OC)C(O)=C13 |
Target Point | STAT3 |
Passage | JAK/STAT Signaling |
Background | Casticin can inhibit the activation of STAT3. |
Biological Activity | Casticin 具有抗有丝分裂和抗炎活性。Casticin 能够抑制 STAT3 的活化[1-3]。 |
In Vitro | Casticin(0.2-1.0μM)剂量依赖性地抑制KB细胞的增殖,在第3天IC50为0.23μM,而对3T3 Swiss Albino和TIG-103细胞没有显著抑制作用。 Casticin(0.6μM)改变纺锤体形态,部分有丝分裂纺锤体破坏或纺锤体紊乱[1]。 Casticin(0-40μM)剂量依赖性地抑制LX2细胞的增殖。 Casticin(40μM)抑制L02细胞增殖并诱导细胞凋亡。通过评估TGF-β,胶原α1(I),MMP-2,MMP-9,TIMP-1和TIMP-2的mRNA水平,Casticin抑制TGF-β1对LX2细胞ECM沉积的纤维化作用[2]。 Casticin(0-8μM)降低了786-O,YD-8和HN-9细胞的活力,但对正常HEL 299细胞没有显著影响。 Casticin(5μM)增加裂解caspase-3和PPAR,降低B细胞淋巴瘤 - 特大型(Bcl-xl),Bcl-2,IAP-1/-2,血管内皮生长因子(VEGF),基质的水平786-O,YD-8和HN-9细胞中的金属肽酶9(MMP-9)和环氧合酶2(COX-2)蛋白。 Casticin(5μM)也促进凋亡细胞死亡,抑制肿瘤细胞中的组成型活性STAT3,通过改变上游STAT3调节剂的活性调节STAT3活化,并消除IL-6诱导的STAT3活化。此外,Casticin(2.5μM)增强了786-O细胞中电离辐射的作用,并增强了放疗的治疗效果[3]。 |
In Vivo | Casticin(20 mg/kg,po)对CCl4和BDL诱导的肝损伤小鼠的肝脏有毒性作用。 Casticin在体内减弱由CCl4或BDL诱导的肝纤维化。 Casticin通过阻断体内TGF-β/ Smad信号传导抑制HSC活化和胶原基质表达[2]。 |
Cell Experiment | 将LX-2细胞或L02细胞以每孔5×103个细胞的密度接种在96孔板中,并在含有血清的生长培养基中用Casticin(0-40μM)处理48小时。使用CCK-8测定试剂盒测定细胞增殖[2]。 |
Animal Experiment | 小鼠[2]将体重为20-30g的6-8周龄的雄性小鼠保持在温度受控的房间中,其具有交替的12小时黑暗和光照循环。将总共32只小鼠随机分成4组,每组8只动物:对照,Casticin,CCl4和CCl4 + Casticin。为了诱导肝纤维化,将溶解在橄榄油(20%)中的CCl4腹膜内注射到CCl4和CCl4 + Casticin组中的小鼠(1.0mL/kg体重)中,每周两次,持续六周。对照组和Casticin组小鼠注射等量的橄榄油。将Casticin溶于0.25%Tween-80中。用CCl4或橄榄油处理6周后,Casticin组和CCl4 + Casticin组小鼠每天通过胃管灌胃接受Casticin(20 mg/kg)两周,其他两组给予0.25%的当量体积吐温80。在8周干预期后,在3%戊巴比妥钠麻醉(40mg/kg ip)下对小鼠进行安乐死,并收集来自所有动物的肝脏和血液。通过离心(1600g,15分钟)获得血清并储存在-20℃以进一步检查[2]。 |
Data Literature Source | [1]. Kobayakawa J,et al. G2-M arrest and antimitotic activity mediated by casticin,a flavonoid isolated from Viticis Fructus (Vitex rotundifolia Linne fil.). Cancer Lett. 2004 May 10;208(1):59-64. [2]. Zhou L,et al. Casticin attenuates liver fibrosis and hepatic stellate cell activation by blocking TGF-β/Smad signaling pathway. Oncotarget. 2017 Apr 27;8(34):56267-56280. [3]. Lee JH,et al. Casticin inhibits growth and enhances ionizing radiation-induced apoptosis through the suppression of STAT3 signaling cascade. J Cell Biochem. 2018 Dec 5 |
Unit | Piece |
Specification | 5mg 10mg 20mg |
Casticin 能够抑制 STAT3 的活化。
Remark:These protocols are for reference only. Solarbio does not independently validate these methods.
Note:
1. The products are all for scientific research use only. Do not use it for medical, clinical diagnosis or treatment, food and cosmetics, etc. Do not store them in ordinary residential areas.
2. For your safety and health, please wear laboratory clothes, disposable gloves and masks.
3. The experimental results may be affected by many factors, after-sale service is limited to the product itself and does not involve other compensation.
Sorry, there is no more information.
Sorry, there is no more information.